Clinical trial
Aerobic Fitness or Muscle Mass Training to Improve Colorectal Cancer Outcome (AMICO). The Effects of Exercise on Chemotherapy Dose Modification and Progression Free Survival in Patients With Metastatic Colorectal Cancer
NCT04754672 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Aerobic Fitness or Muscle Mass Training to Improve Colorectal Cancer Outcome (AMICO). The Effects of Exercise on Chemotherapy Dose Modification and Progression Free Survival in Patients With Metastatic Colorectal Cancer
- Lead sponsor
- Radboud University Medical Center
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- March 2, 2021
- Completion date
- December 31, 2026
- Enrollment
- 228 (estimated)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.
chemotherapeutic toxicity, colorectal cancer, lifestyle, survivorship